This inventor holds 2 USPTO granted patents, plus 2 CIPO patents. Top assignees: Tohoku University, Brain Innovation Co., Inc.. Active years: 2019-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,054 
1 out of 1 Years Active: 2019-2023
Title: Shigeki Moriguchi: Innovator in Cognitive Disease Treatment
Introduction
Shigeki Moriguchi is a notable inventor based in Miyagi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cognitive diseases and disorders. His innovative work has led to the development of several important compounds.
Latest Patents
Moriguchi holds 2 patents that focus on pharmaceutical compositions for treating cognitive diseases. His latest patents include "Adamantylmethylamine derivative and use thereof as pharmaceutical," which provides a composition for treating or preventing cognitive disorders using a specific compound. Another patent, "Adamantane derivative and use thereof," also addresses the treatment of cognitive diseases with a similar approach.
Career Highlights
Throughout his career, Shigeki Moriguchi has worked with esteemed institutions such as Tohoku University and Brain Innovation Co., Inc. His research has been pivotal in advancing the understanding and treatment of cognitive disorders.
Collaborations
Moriguchi has collaborated with notable colleagues, including Yoshiharu Iwabuchi and Koji Fukunaga. Their combined expertise has contributed to the success of their research endeavors.
Conclusion
Shigeki Moriguchi's innovative work in the pharmaceutical field highlights his commitment to improving treatments for cognitive diseases. His patents and collaborations reflect his significant impact on medical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile